Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Irritable Bowel Syndrome, January 2018

Free Subscription


Abstracts

Retrieve all available abstracts of the following 103 articles:
HTML format


 

Single Articles

  1. BASSOTTI G, Macchioni L, Corazzi L, Marconi P, et al
    Clostridium difficile-related postinfectious IBS: a case of enteroglial microbiological stalking and/or the solution of a conundrum?
    Cell Mol Life Sci. 2017 Dec 28. pii: 10.1007/s00018-017-2736.
    Abstract    

    Abstract available

  2. BANERJEE A, Sarkhel S, Sarkar R, Dhali GK, et al
    Anxiety and Depression in Irritable Bowel Syndrome.
    Indian J Psychol Med. 2017;39:741-745.
    Abstract    

    Abstract available

  3. BINIENDA A, Storr M, Fichna J, Salaga M, et al
    Efficacy and safety of serotonin receptor ligands in the treatment of irritable bowel syndrome: a review.
    Curr Drug Targets. 2017 Dec 27. pii: CDT-EPUB-87609.
    Abstract    

    Abstract available

  4. SUGAWARA N, Sato K, Takahashi I, Satake R, et al
    Irritable bowel syndrome and quality of life in a community-dwelling population in Japan.
    Int J Psychiatry Med. 2017 Jan 1:91217417749791. doi: 10.1177/0091217417749791.
    Abstract    

    Abstract available

  5. YU T, Jiang L, Lin L
    [Update of the Rome IIII( criteria for functional constipation].
    Zhonghua Wei Chang Wai Ke Za Zhi. 2017;20:1334-1338.
    Abstract    

    Abstract available

  6. SANTOS CD, Ratzlaff RA, Meder JC, Atwal PS, et al
    Ornithine Transcarbamylase Deficiency: If at First You Do Not Diagnose, Try and Try Again.
    Case Rep Crit Care. 2017;2017:8724810.
    Abstract    

    Abstract available

  7. MELIDIS C, Denham SL, Hyland ME
    A test of the adaptive network explanation of functional disorders using a machine learning analysis of symptoms.
    Biosystems. 2017 Dec 23. pii: S0303-2647(17)30243.
    Abstract    

    Abstract available

  8. STAUDACHER HM, Kurien M, Whelan K
    Nutritional implications of dietary interventions for managing gastrointestinal disorders.
    Curr Opin Gastroenterol. 2017 Dec 22. doi: 10.1097/MOG.0000000000000421.
    Abstract    

    Abstract available

  9. FUKUDO S, Nakajima A, Fujiyama Y, Kosako M, et al
    Determining an optimal dose of linaclotide for use in Japanese patients with irritable bowel syndrome with constipation: A phase II randomized, double-blind, placebo-controlled study.
    Neurogastroenterol Motil. 2017 Dec 26. doi: 10.1111/nmo.13275.
    Abstract    

    Abstract available

  10. YOUNG S, Burns MK, DiFrancesco L, Nezhat A, et al
    Diagnostic and treatment guidelines for gastrointestinal and genitourinary endometriosis.
    J Turk Ger Gynecol Assoc. 2017;18:200-209.
    Abstract    

    Abstract available

  11. FOSTER JA, Rinaman L, Cryan JF
    Stress & the gut-brain axis: Regulation by the microbiome.
    Neurobiol Stress. 2017;7:124-136.
    Abstract    

    Abstract available

  12. HAJIZADEH MALEKI B, Tartibian B, Mooren FC, FitzGerald LZ, et al
    Low-to-moderate intensity aerobic exercise training modulates irritable bowel syndrome through antioxidative and inflammatory mechanisms in women: Results of a randomized controlled trial.
    Cytokine. 2017;102:18-25.
    Abstract    

    Abstract available

  13. MANZOLI L, Flacco ME, Marzuillo C, Lopetuso L, et al
    Prevalence of severe irritable bowel syndrome among Italian adults. A meta-analysis.
    Eur Rev Med Pharmacol Sci. 2017;21:5751-5764.
    Abstract    

    Abstract available

  14. AASBRENN M, Valeur J, Farup PG
    Evaluation of a faecal dysbiosis test for irritable bowel syndrome in subjects with and without obesity.
    Scand J Clin Lab Invest. 2017 Dec 22:1-5. doi: 10.1080/00365513.2017.1419372.
    Abstract    

    Abstract available

  15. SEBASTIAN DOMINGO JJ, Sanchez Sanchez C
    From the intestinal flora to the microbiome.
    Rev Esp Enferm Dig. 2017;110.
    Abstract    

    Abstract available

  16. FIEST KM, Greenfield J, Metz LM, Patten SB, et al
    Discriminative ability of quality of life measures in multiple sclerosis.
    Health Qual Life Outcomes. 2017;15:246.
    Abstract    

    Abstract available

  17. MAAN JS, Saadabadi A, Chand SP, Whitten RA, et al
    FABP4 blocker attenuates colonic hypomotility and modulates white adipose tissue-derived hormone levels in mouse models mimicking constipation-predominant IBS.
    Neurogastroenterol Motil. 2017 Dec 20. doi: 10.1111/nmo.13272.
    Abstract    

    Abstract available

  18. TSUCHIYA K
    The significance of infectious disease and microbiota in functional gastrointestinal disorders.
    J Gen Fam Med. 2017;18:27-31.
    Abstract    

    Abstract available

  19. HULME K, Chilcot J, Smith MA
    Doctor-patient relationship and quality of life in Irritable Bowel Syndrome: an exploratory study of the potential mediating role of illness perceptions and acceptance.
    Psychol Health Med. 2017 Dec 20:1-11. doi: 10.1080/13548506.2017.1417613.
    Abstract    

    Abstract available

  20. KAZEMIAN A, Toghiani A, Shafiei K, Afshar H, et al
    Evaluating the efficacy of mixture of Boswellia carterii, Zingiber officinale, and Achillea millefolium on severity of symptoms, anxiety, and depression in irritable bowel syndrome patients.
    J Res Med Sci. 2017;22:120.
    Abstract    

    Abstract available

  21. HOU Q, Huang Y, Zhu S, Li P, et al
    MiR-144 Increases Intestinal Permeability in IBS-D Rats by Targeting OCLN and ZO1.
    Cell Physiol Biochem. 2017;44:2256-2268.
    Abstract    

    Abstract available

  22. QUIGLEY EMM
    Are diets the answers to colon ills? Food, irritable bowel syndrome and the microbiome.
    Curr Opin Gastroenterol. 2017 Dec 18. doi: 10.1097/MOG.0000000000000420.
    Abstract    



  23. ADENIYI OF, Adenike Lesi O, Olatona FA, Esezobor CI, et al
    Irritable bowel syndrome in adolescents in Lagos.
    Pan Afr Med J. 2017;28:93.
    Abstract    

    Abstract available

  24. YUSOF N, Hamid N, Ma ZF, Lawenko RM, et al
    Exposure to environmental microbiota explains persistent abdominal pain and irritable bowel syndrome after a major flood.
    Gut Pathog. 2017;9:75.
    Abstract    

    Abstract available

  25. SINAGRA E, Raimondo D, Pompei G, Fusco G, et al
    Focal active colitis as a predictor of inflammatory bowel disease: results from a single-center experience.
    J Biol Regul Homeost Agents. 2017;31:1119-1125.
    Abstract    

    Abstract available

  26. STALLER K, Barshop K, Ananthakrishnan AN, Kuo B, et al
    Number of retained radiopaque markers on a colonic transit study does not correlate with symptom severity or quality of life in chronic constipation.
    Neurogastroenterol Motil. 2017 Dec 18. doi: 10.1111/nmo.13269.
    Abstract    

    Abstract available

  27. GUAN T, Li T, Cai W, Huang D, et al
    HTR3A and HTR3E gene polymorphisms and diarrhea predominant irritable bowel syndrome risk: evidence from a meta-analysis.
    Oncotarget. 2017;8:100459-100468.
    Abstract    

    Abstract available

  28. CHUA CS, Huang SY, Cheng CW, Bai CH, et al
    Fatty acid components in Asian female patients with irritable bowel syndrome.
    Medicine (Baltimore). 2017;96:e9094.
    Abstract    

    Abstract available

  29. CHIANG IN, Huang CY, Pu YS, Chang CH, et al
    Association between ischaemic bowel syndromes and androgen deprivation therapy in patients with prostate cancer: a retrospective cohort study.
    BMJ Open. 2017;7:e012950.
    Abstract    

    Abstract available

  30. GEORGESCU D, Reisz D, Gurban CV, Georgescu LA, et al
    Migraine in young females with irritable bowel syndrome: still a challenge.
    Neuropsychiatr Dis Treat. 2017;14:21-28.
    Abstract    

    Abstract available

  31. QUIGLEY EMM
    The Gut-Brain Axis and the Microbiome: Clues to Pathophysiology and Opportunities for Novel Management Strategies in Irritable Bowel Syndrome (IBS).
    J Clin Med. 2018;7.
    Abstract    

    Abstract available

  32. VANNUCCHI MG, Evangelista S
    Experimental Models of Irritable Bowel Syndrome and the Role of the Enteric Neurotransmission.
    J Clin Med. 2018;7.
    Abstract    

    Abstract available

  33. HALPERT A
    Irritable Bowel Syndrome: Patient-Provider Interaction and Patient Education.
    J Clin Med. 2018;7.
    Abstract    

    Abstract available

  34. JUNCADELLA AC, Moss A
    Fecal microbiota transplantation as a possible treatment of irritable bowel syndrome.
    Ann Transl Med. 2017;5:506.
    Abstract    



  35. CRAVEN LJ, Silverman M, Burton JP
    Transfer of altered behaviour and irritable bowel syndrome with diarrhea (IBS-D) through fecal microbiota transplant in mouse model indicates need for stricter donor screening criteria.
    Ann Transl Med. 2017;5:490.
    Abstract    



  36. PRINCIPI N, Cozzali R, Farinelli E, Brusaferro A, et al
    Gut dysbiosis and irritable bowel syndrome: the potential role of probiotics.
    J Infect. 2017 Dec 29. pii: S0163-4453(17)30412.
    Abstract    

    Abstract available

  37. AIT-BELGNAOUI A, Payard I, Rolland C, Harkat C, et al
    Bifidobacterium longum and Lactobacillus helveticus Synergistically Suppress Stress-related Visceral Hypersensitivity Through Hypothalamic-Pituitary-Adrenal Axis Modulation.
    J Neurogastroenterol Motil. 2018;24:138-146.
    Abstract    

    Abstract available

  38. NAN J, Zhang L, Chen Q, Zong N, et al
    White Matter Microstructural Similarity and Diversity of Functional Constipation and Constipation-predominant Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2018;24:107-118.
    Abstract    

    Abstract available

  39. DUSSIK CM, Hockley M, Grozic A, Kaneko I, et al
    Gene Expression Profiling and Assessment of Vitamin D and Serotonin Pathway Variations in Patients With Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2018;24:96-106.
    Abstract    

    Abstract available

  40. TANAKA Y, Kanazawa M, Palsson OS, Tilburg MAV, et al
    Increased Postprandial Colonic Motility and Autonomic Nervous System Activity in Patients With Irritable Bowel Syndrome: A Prospective Study.
    J Neurogastroenterol Motil. 2018;24:87-95.
    Abstract    

    Abstract available

  41. LEE HF, Liu PY, Wang YP, Tsai CF, et al
    Sexual Abuse Is Associated With an Abnormal Psychological Profile and Sleep Difficulty in Patients With Irritable Bowel Syndrome in Taiwan.
    J Neurogastroenterol Motil. 2018;24:79-86.
    Abstract    

    Abstract available

  42. MEERVELD BG, Johnson AC
    Mechanisms of Stress-induced Visceral Pain.
    J Neurogastroenterol Motil. 2018;24:7-18.
    Abstract    

    Abstract available

  43. CHEN JM, Liu T, Gao S, Tong XD, et al
    Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    World J Gastroenterol. 2017;23:8235-8247.
    Abstract    

    Abstract available

  44. ZHAO K, Yu L, Wang X, He Y, et al
    Clostridium butyricum regulates visceral hypersensitivity of irritable bowel syndrome by inhibiting colonic mucous low grade inflammation through its action on NLRP6.
    Acta Biochim Biophys Sin (Shanghai). 2018 Jan 10. pii: 4796862.
    Abstract    

    Abstract available

  45. PELLICANO R, Ribaldone DG, Astegiano M, Dughera L, et al
    Gastroenterology today: between certainties and news: a meeting held in Turin on May 27, 2017.
    Minerva Gastroenterol Dietol. 2018 Jan 10. pii: S1121-421X.18.02465.
    Abstract    

    Abstract available

  46. ABRAMS DI
    The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report.
    Eur J Intern Med. 2018 Jan 8. pii: S0953-6205(18)30003.
    Abstract    

    Abstract available

  47. BRUUN WYLLER V, Bjorneklett A, Brubakk O, Festvag L, et al
    Laypersons Knowledge and Perceptions of Irritable Bowel Syndrome as Potential Barriers to Care.
    J Adv Nurs. 2018 Jan 10. doi: 10.1111/jan.13521.
    Abstract    

    Abstract available

  48. WU CC, Chung SD, Lin HC
    Endometriosis increased the risk of bladder pain syndrome/interstitial cystitis: A population-based study.
    Neurourol Urodyn. 2018 Jan 10. doi: 10.1002/nau.23462.
    Abstract    

    Abstract available

  49. SZILAGYI A, Xue X
    Comparison of geographic distributions of Irritable Bowel Syndrome with Inflammatory Bowel Disease fail to support common evolutionary roots: Irritable Bowel Syndrome and Inflammatory Bowel Diseases are not related by evolution.
    Med Hypotheses. 2018;110:31-37.
    Abstract    

    Abstract available

  50. BOUCHOUCHA M, Mary F, Bon C, Bejou B, et al
    Sleep quality and functional gastrointestinal disorders. A psychological issue.
    J Dig Dis. 2018 Jan 8. doi: 10.1111/1751-2980.12577.
    Abstract    

    Abstract available

  51. QI Q, Zhang Y, Chen F, Zuo X, et al
    Ramosetron for the treatment of irritable bowel syndrome with diarrhea: a systematic review and meta-analysis of randomized controlled trials.
    BMC Gastroenterol. 2018;18:5.
    Abstract    

    Abstract available

  52. ENCK P, Frieling T, Schemann M
    [Irritable bowel syndrome - disection of a disease. A 13-steps polemic].
    Z Gastroenterol. 2017;55:e1.
    Abstract    



  53. MALONE M, Tsai G
    The evidence for herbal and botanical remedies, Part 1.
    J Fam Pract. 2018;67:10-16.
    Abstract    

    Abstract available

  54. CHEN BR, Du LJ, He HQ, Kim JJ, et al
    Fructo-oligosaccharide intensifies visceral hypersensitivity and intestinal inflammation in a stress-induced irritable bowel syndrome mouse model.
    World J Gastroenterol. 2017;23:8321-8333.
    Abstract    

    Abstract available

  55. HENNINGSEN P, Zipfel S, Sattel H, Creed F, et al
    Management of Functional Somatic Syndromes and Bodily Distress.
    Psychother Psychosom. 2018;87:12-31.
    Abstract    

    Abstract available

  56. BROGAN K
    Remote Healing of Bipolar Disorder, Eating Disorder Not Otherwise Specified, Posttraumatic Stress Disorder, Fibromyalgia, and Irritable Bowel Syndrome Through Lifestyle Change.
    Adv Mind Body Med. 2017;31:4-9.
    Abstract    

    Abstract available

  57. DI PIERRO F, Putignano P, Villanova N
    Retrospective analysis of the effects of a highly standardized mixture of Berberis aristata, Silybum marianum, and monacolins K and KA in diabetic patients with dyslipidemia.
    Acta Biomed. 2018;88:462-469.
    Abstract    

    Abstract available

  58. MELCHIOR C, Bril L, Leroi AM, Gourcerol G, et al
    Are characteristics of abdominal pain helpful to identify patients with visceral hypersensitivity in irritable bowel syndrome? Results of a prospective study.
    Neurogastroenterol Motil. 2018 Jan 18. doi: 10.1111/nmo.13290.
    Abstract    

    Abstract available

  59. HAPPEL AU, Barnabas SL, Froissart R, Passmore JS, et al
    Weighing in on the risks and benefits of probiotic use in HIV-infected and immunocompromised populations.
    Benef Microbes. 2018 Jan 18:1-8. doi: 10.3920/BM2017.0106.
    Abstract    

    Abstract available

  60. LUTT A, Michel K, Kruger D, Volz MS, et al
    High prevalence and functional effects of serum antineuronal antibodies in patients with gastrointestinal disorders.
    Neurogastroenterol Motil. 2018 Jan 18. doi: 10.1111/nmo.13292.
    Abstract    

    Abstract available

  61. YAOITA F, Muto M, Murakami H, Endo S, et al
    Involvement of peripheral alpha2A adrenoceptor in the acceleration of gastrointestinal transit and abdominal visceral pain induced by intermittent deprivation of REM sleep.
    Physiol Behav. 2018 Jan 12. pii: S0031-9384(18)30016.
    Abstract    

    Abstract available

  62. WHELAN K, Martin LD, Staudacher HM, Lomer MCE, et al
    The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice.
    J Hum Nutr Diet. 2018 Jan 15. doi: 10.1111/jhn.12530.
    Abstract    

    Abstract available

  63. MAHBOUBI M
    Therapeutic Potential of Zataria multiflora Boiss in Treatment of Irritable Bowel Syndrome (IBS).
    J Diet Suppl. 2018 Jan 15:1-10. doi: 10.1080/19390211.2017.1409852.
    Abstract    

    Abstract available

  64. HARPER A, Naghibi MM, Garcha D
    The Role of Bacteria, Probiotics and Diet in Irritable Bowel Syndrome.
    Foods. 2018;7.
    Abstract    

    Abstract available

  65. PIMENTEL M
    Evidence-based management of irritable bowel syndrome with diarrhea.
    Am J Manag Care. 2018;24.
    Abstract    

    Abstract available

  66. PIMENTEL M
    Evidence-based management of irritable bowel syndrome with diarrhea.
    Am J Manag Care. 2018;24.
    Abstract    

    Abstract available

  67. ACAR BA, Acar MAG, Acar T, Varim C, et al
    Patients with primary restless legs syndrome have higher prevalence of autonomic dysfunction and irritable bowel syndrome.
    Singapore Med J. 2018 Jan 26. doi: 10.11622/smedj.2018010.
    Abstract    

    Abstract available

  68. HE X, Cui LH, Wang XH, Yan ZH, et al
    Modulation of inflammation by toll-like receptor 4/nuclear factor-kappa B in diarrhea-predominant irritable bowel syndrome.
    Oncotarget. 2017;8:113957-113965.
    Abstract    

    Abstract available

  69. JOHN AP
    A positive diagnosis of irritable bowel syndrome does not give immunity from developing bowel cancer.
    Br J Gen Pract. 2018;68:70.
    Abstract    



  70. CAVIGLIA GP, Ribaldone DG, Rosso C, Saracco GM, et al
    Fecal calprotectin: beyond intestinal organic diseases.
    Panminerva Med. 2018 Jan 25. pii: S0031-0808.18.03405.
    Abstract    

    Abstract available

  71. WILLIAMS CE, Williams EA, Corfe BM
    Vitamin D status in irritable bowel syndrome and the impact of supplementation on symptoms: what do we know and what do we need to know?
    Eur J Clin Nutr. 2018 Jan 25. pii: 10.1038/s41430-017-0064.
    Abstract    

    Abstract available

  72. KJELLMO CA, Johnsen PH, Hovland A, Lappegard KT, et al
    Fecal microbiota transplantation in irritable bowel syndrome does not affect plasma lipids or LDL and HDL subfractions.
    Atherosclerosis. 2017;263:e206.
    Abstract    



  73. UGRAS N, Yerci O, Ozgun G, Deligonul A, et al
    Irritable bowel syndrome and visceral hypersensitivity : risk factors and pathophysiological mechanisms.
    Acta Gastroenterol Belg. 2017;80:31-37.
    Abstract    

    Abstract available

  74. LIU DR, Xu XJ, Yao SK
    Increased intestinal mucosal leptin levels in patients with diarrhea-predominant irritable bowel syndrome.
    World J Gastroenterol. 2018;24:46-57.
    Abstract    

    Abstract available

  75. RADOVANOVIC-DINIC B, Tesic-Rajkovic S, Grgov S, Petrovic G, et al
    Irritable bowel syndrome - from etiopathogenesis to therapy.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2018.
    Abstract    

    Abstract available

  76. LOPEZ-REQUENA A, Boonen B, Van Gerven L, Hellings PW, et al
    [Effects of heat-sensitive moxibustion on HPA axis in rats with irritable bowel syndrome].
    Zhongguo Zhen Jiu. 2017;37:1315-21.
    Abstract    

    Abstract available

  77. QIN Y, Yi W, Lin S, Yang C, et al
    [Clinical effect of abdominal acupuncture for diarrhea irritable bowel syndrome].
    Zhongguo Zhen Jiu. 2017;37:1265-8.
    Abstract    

    Abstract available

  78. UNO Y
    Letter: low-FODMAP diet for exercise-induced gastrointestinal syndrome.
    Aliment Pharmacol Ther. 2017;46:1021-1022.
    Abstract    



  79. COSTA RJS, Snipe RMJ, Kitic CM, Gibson PR, et al
    Letter: low-FODMAP diet for exercise-induced gastrointestinal syndrome-Authors' reply.
    Aliment Pharmacol Ther. 2017;46:1023-1024.
    Abstract    



  80. ALEXAKIS C, Kumar S, Saxena S, Hotopf M, et al
    Editorial: depression in the setting of inflammatory bowel disease means we have failed to provide early, effective, psychosocial care-authors' reply.
    Aliment Pharmacol Ther. 2017;46:554-555.
    Abstract    



  81. DAMAS OM, Schwartz SJ, Abreu MT
    Editorial: migration studies to determine risk and cause of inflammatory bowel disease-authors' reply.
    Aliment Pharmacol Ther. 2017;46:467.
    Abstract    



  82. QUIGLEY EMM
    Editorial: food for thought-the low-FODMAP diet and IBS in perspective.
    Aliment Pharmacol Ther. 2017;46:206-207.
    Abstract    



  83. SOOD R, Gracie DJ, Gold MJ, To N, et al
    Editorial: latent class analysis to improve confidence in the diagnosis of IBS - authors' reply.
    Aliment Pharmacol Ther. 2017;45:1268-1269.
    Abstract    



  84. BALLOU S, Lembo A
    Editorial: latent class analysis to improve confidence in the diagnosis of IBS.
    Aliment Pharmacol Ther. 2017;45:1267-1268.
    Abstract    



  85. SAYUK GS, Kanuri N, Gyawali CP, Gott BM, et al
    Opioid medication use in patients with gastrointestinal diagnoses vs unexplained gastrointestinal symptoms in the US Veterans Health Administration.
    Aliment Pharmacol Ther. 2018 Jan 12. doi: 10.1111/apt.14503.
    Abstract    

    Abstract available

  86. MUIR JG, Iacovou M
    Editorial: irritable bowel syndrome-in addition to having properly-trained dietitians, is it time to add a yoga teacher to our multidisciplinary team?
    Aliment Pharmacol Ther. 2018;47:432-433.
    Abstract    



  87. UNO Y
    Letter: irritable bowel syndrome-how a low-FODMAP diet or yoga might help.
    Aliment Pharmacol Ther. 2018;47:444-445.
    Abstract    



  88. SCHUMANN D, Cramer H
    Editorial: irritable bowel syndrome-in addition to having properly-trained dietitians, is it time to add a yoga teacher to our multidisciplinary team? Authors' reply.
    Aliment Pharmacol Ther. 2018;47:433-434.
    Abstract    



  89. SCHUMANN D, Cramer H
    Letter: irritable bowel syndrome-how a low-FODMAP diet or yoga might help. Authors' reply.
    Aliment Pharmacol Ther. 2018;47:445-446.
    Abstract    



  90. CHUMPITAZI BP, Kearns GL, Shulman RJ
    Review article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders.
    Aliment Pharmacol Ther. 2018 Jan 26. doi: 10.1111/apt.14519.
    Abstract    

    Abstract available

  91. SWEENEY L, Moss-Morris R, Czuber-Dochan W, Meade L, et al
    Systematic review: psychosocial factors associated with pain in inflammatory bowel disease.
    Aliment Pharmacol Ther. 2018 Jan 22. doi: 10.1111/apt.14493.
    Abstract    

    Abstract available

  92. VALEUR J, Smastuen MC, Knudsen T, Lied GA, et al
    Exploring Gut Microbiota Composition as an Indicator of Clinical Response to Dietary FODMAP Restriction in Patients with Irritable Bowel Syndrome.
    Dig Dis Sci. 2018 Jan 4. pii: 10.1007/s10620-017-4893.
    Abstract    

    Abstract available

  93. JANG DE, Bae JH, Chang YJ, Lee YH, et al
    Neuronal Nitric Oxide Synthase Is a Novel Biomarker for the Interstitial Cells of Cajal in Stress-Induced Diarrhea-Dominant Irritable Bowel Syndrome.
    Dig Dis Sci. 2018 Jan 25. pii: 10.1007/s10620-018-4933.
    Abstract    

    Abstract available

  94. BLACKETT JW, Shamsunder M, Reilly NR, Green PHR, et al
    Characteristics and comorbidities of inpatients without celiac disease on a gluten-free diet.
    Eur J Gastroenterol Hepatol. 2018 Jan 8. doi: 10.1097/MEG.0000000000001071.
    Abstract    

    Abstract available

  95. CHANG L, Di Lorenzo C, Farrugia G, Hamilton FA, et al
    Functional Bowel Disorders: A Roadmap to Guide the Next Generation of Research.
    Gastroenterology. 2017 Dec 27. pii: S0016-5085(17)36714.
    Abstract    

    Abstract available

  96. MEYER C, Vassar M
    The Fragility of Probiotic Bifidobacterium longum NCC3001 Use for Depression in Patients With Irritable Bowel Syndrome.
    Gastroenterology. 2018 Jan 17. pii: S0016-5085(17)36667.
    Abstract    



  97. THINGHOLM L, Ruhlemann M, Wang J, Hubenthal M, et al
    Sucrase-isomaltase 15Phe IBS risk variant in relation to dietary carbohydrates and faecal microbiota composition.
    Gut. 2018 Jan 13. pii: gutjnl-2017-315841. doi: 10.1136/gutjnl-2017-315841.
    Abstract    



  98. ADDANTE R, Naliboff B, Shih W, Presson AP, et al
    Predictors of Health-related Quality of Life in Irritable Bowel Syndrome Patients Compared With Healthy Individuals.
    J Clin Gastroenterol. 2018 Jan 18. doi: 10.1097/MCG.0000000000000978.
    Abstract    

    Abstract available

  99. ONO M, Kato M, Miyamoto S, Tsuda M, et al
    Multicenter observational study on functional bowel disorders diagnosed using Rome III diagnostic criteria in Japan.
    J Gastroenterol. 2018 Jan 5. pii: 10.1007/s00535-017-1428.
    Abstract    

    Abstract available

  100. YANG Y, Fang J, Guo X, Dai N, et al
    Linaclotide in Irritable Bowel Syndrome with Constipation: A Phase 3 Randomized Trial in China and Other Regions.
    J Gastroenterol Hepatol. 2018 Jan 10. doi: 10.1111/jgh.14086.
    Abstract    

    Abstract available

  101. BERENS S, Stroe-Kunold E, Kraus F, Tesarz J, et al
    Pilot-RCT of an integrative group therapy for patients with refractory irritable bowel syndrome (ISRCTN02977330).
    J Psychosom Res. 2018;105:72-79.
    Abstract    

    Abstract available

  102. SIBELLI A, Chalder T, Everitt H, Chilcot J, et al
    Positive and negative affect mediate the bidirectional relationship between emotional processing and symptom severity and impact in irritable bowel syndrome.
    J Psychosom Res. 2018;105:1-13.
    Abstract    

    Abstract available

  103. LI DY, Dai YK, Zhang YZ, Huang MX, et al
    Systematic review and meta-analysis of traditional Chinese medicine in the treatment of constipation-predominant irritable bowel syndrome.
    PLoS One. 2017;12:e0189491.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;